Friday, December 5, 2025

LATEST NEWS

PHARMA

Medtech

Real Estate

Real Estate

Curium Pharma Selects Boston Seaport for New Global Headquarters

Life Sciences Times - 0
BOSTON, Mass. — Curium Pharma, a global player in nuclear cancer medicine, is relocating its worldwide headquarters to Boston’s Seaport District after securing a...

Instem Opens New Global Headquarters in Boston

Labshares Opens New Watertown Site, Doubles Its Footprint and Extends Shared-Lab Access to More Biotech Firms

Life Sciences

Life Sciences and Investment Leaders at BioFuture 2025 Signal Renewed Optimism in Health and Biotech Sectors

Life Sciences Times - 0
NEW YORK — Demy-Colton’s BioFuture 2025 conference concluded in New York and virtually this week, highlighting renewed confidence in the biotech sector and the...

ONDEX Automation Acquires PlantOPS Consulting to Expand Life Sciences Capabilities

Life Sciences Times - 0
CHICAGO — ONDEX Automation has acquired PlantOPS Consulting, a provider of Manufacturing Execution System (MES) implementation and consulting services for pharmaceutical, biotechnology, and medical...

Gut Neurons Decoded: New Study Reveals How Food Allergies and Microbes Rewire the Gut’s Nervous System

Life Sciences Times - 0
CAMBRIDGE, Mass. — A landmark study published in Science by researchers at the Broad Institute of MIT and Harvard, in collaboration with the Food...

ASU’s New School of Medicine Receives Preliminary Accreditation, Major Gift, and New Name

Life Sciences Times - 0
PHOENIX, Ariz. — Arizona State University announced that its new medical school has received preliminary accreditation from the Liaison Committee on Medical Education (LCME),...

Loomis Sayles Partners with ICE Climate to Enhance Global Climate Risk Analysis

Life Sciences Times - 0
BOSTON, Mass. — Intercontinental Exchange, Inc. (NYSE: ICE), a global provider of data and technology, announced that Loomis, Sayles & Company has chosen ICE...

Today's Headlines

Amylyx Pharmaceuticals Reports New Cohort 1 Safety Data for AMX0114 in ALS from First-in-Human LUMINA Trial

Life Sciences Times - 0
Pharma
CAMBRIDGE, Mass. — Amylyx Pharmaceuticals, Inc. announced new early safety and tolerability findings from Cohort 1 of its Phase 1 LUMINA trial evaluating AMX0114...
Advertisment

LATEST ARTICLES

123...767Page 1 of 767

Most Popular

Load more

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv